Further to DrugAlert vol 1018, HPS Pharmacies wish to advise that Bridgewest is also experiencing a supply interruption for lidocaine 2% ampoules as follows:
Lidocaine Injection
Lidocaine (lignocaine) HCl 2% (400mg/20mL)
ARTG 49295
Lidocaine Injection
Lidocaine (lignocaine) HCl 2% (100mg/5mL)
ARTG 49293
Normal supplies of Bridgewest Lidocaine Injection 2% are expected to return in late February 2026.
Alternative brands of lidocaine 2% are available, including Lidocaine Apotex, Lidocaine Noridem, and Xylocaine. The approved indications and administration instructions may vary between brands. Please consult the product information for further details.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Bridgewest on (08) 9362 0666, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates